HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eriko Toyoda Selected Research

N- (2- (4- methoxybenzenesulfonamide)phenyl)- 3,5- dimethyl- 4- isoxazolcarboxamide

11/2004NK95806, a newly synthesized microtubule-disrupting agent that suppresses collagen-induced arthritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eriko Toyoda Research Topics

Disease

3Polydactyly (Polydactylism)
03/2021 - 01/2017
3Knee Osteoarthritis
03/2021 - 01/2020
3Neoplasms (Cancer)
02/2009 - 01/2008
2Osteoarthritis
03/2021 - 12/2019
2Arthritis (Polyarthritis)
12/2018 - 11/2004
2Pain (Aches)
11/2018 - 11/2017
2Glomerulonephritis
09/2008 - 11/2006
2Proteinuria
09/2008 - 11/2006
2Hematuria
09/2008 - 11/2006
2Vitreous Hemorrhage
04/2008 - 02/2008
1Joint Diseases (Joint Disease)
03/2021
1Necrosis
01/2020
1Melanoma (Melanoma, Malignant)
01/2018
1Poisoning
02/2009
1Breast Neoplasms (Breast Cancer)
02/2009
1Vasculitis (Vasculitides)
09/2008
1Hypersensitivity (Allergy)
08/2008
1Hemorrhage
05/2008
1Uveal Effusion Syndrome
05/2008
1Diabetic Retinopathy (Retinopathy, Diabetic)
02/2008
1Cataract (Cataracts)
02/2008
1Macular Edema
02/2008
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2006
1Lymphadenopathy
11/2006
1Experimental Arthritis
11/2004

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
03/2021 - 08/2008
2Indicators and Reagents (Reagents)IBA
11/2018 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
02/2009 - 01/2008
2Immunosuppressive Agents (Immunosuppressants)IBA
09/2008 - 11/2006
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2008 - 11/2006
2NK314IBA
08/2008 - 01/2008
1Biomarkers (Surrogate Marker)IBA
03/2021
1CytokinesIBA
02/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2020
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1SolutionsIBA
01/2020
1Platelet-Derived Growth FactorIBA
01/2020
1Iodoacetic AcidIBA
12/2018
1Glutamine (L-Glutamine)FDA Link
01/2018
1Serine (L-Serine)FDA Link
01/2018
1CytidineIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1PyridoxalIBA
01/2018
1UracilIBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA
02/2009
1IronIBA
02/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2009
1Type I DNA Topoisomerases (Topoisomerase I)IBA
02/2009
1Chelating AgentsIBA
02/2009
1Peroxidase (Myeloperoxidase)IBA
09/2008
1Retinaldehyde (Retinal)IBA
05/2008
1Topoisomerase II InhibitorsIBA
01/2008
1NitrogenIBA
11/2006
1Urea (Carbamide)FDA LinkGeneric
11/2006
1AutoantibodiesIBA
11/2006
1Antinuclear AntibodiesIBA
11/2006
1Antigen-Antibody Complex (Immune Complex)IBA
11/2006
1(S)- 1- (5- hydroxy- 1,5- dimethylhexyl)- 3- (7- (4- methoxyphenyl)- (1,2,4- triazolo(1,5- a)pyrimidin- 2- yl))ureaIBA
11/2006
1Methotrexate (Mexate)FDA LinkGeneric
11/2004
1N- (2- (4- methoxybenzenesulfonamide)phenyl)- 3,5- dimethyl- 4- isoxazolcarboxamideIBA
11/2004

Therapy/Procedure

3Vitrectomy
05/2008 - 02/2008
2Therapeutics
03/2021 - 03/2021
2Transplantation
12/2019 - 12/2018
1Injections
03/2021
1Light Coagulation
05/2008
1Sclerostomy
05/2008
1Phacoemulsification
02/2008
1Intraocular Lens Implantation
02/2008
1Oral Administration
11/2006